Chapter
MENTAL HEALTH
IN UNDERPRIVILEGED CHILDREN:
ANALYSES OF PSYCHOTROPICS
AND MENTAL HEALTH SERVICES
MENTAL HEALTH
IN UNDERPRIVILEGED CHILDREN:
ANALYSES OF PSYCHOTROPICS
AND MENTAL HEALTH SERVICES
Library of Congress Cataloging-in-Publication Data
Chapter 1:
CHILDREN’S MENTAL HEALTH:
CONCERNS REMAIN ABOUT APPROPRIATE SERVICES FOR CHILDREN IN MEDICAID
AND FOSTER CARE
CHILDREN IN MEDICAID TOOK PSYCHOTROPIC MEDICATIONS AT A HIGHER RATE THAN THOSE
WITH PRIVATE INSURANCE, AND MOST CHILDREN
IN MEDICAID WITH A POTENTIAL MENTAL HEALTH NEED DID NOT RECEIVE SERVICES
About 6 Percent of Children in Medicaid Took Psychotropic Medications, and They Were over Twice as Likely as Privately Insured Children to Take an Antipsychotic
About 14 Percent of Children in Medicaid Had a Potential Mental Health Need, but Most Did Not Receive Mental Health Services
CMS and States Have Made Efforts to Ensure That Children Receive Appropriate Mental Health Services, but CMS’s Ability to Monitor Children’s Receipt of Services Is Limited
NEARLY ONE-FIFTH OF FOSTER CHILDREN TOOK PSYCHOTROPIC MEDICATIONS, AND NEARLY ONE-THIRD OF FOSTER CHILDREN WHO MAY HAVE NEEDED MENTAL HEALTH SERVICES DID NOT RECEIVE THEM
ACF Reported That 18 Percent of Foster Children Took Psychotropic Medications
ACF Reported That 30 Percent of Foster Children with a Potential Mental Health Need Did Not Receive Mental Health Services
HHS Has Provided Information to States on Use of Psychotropic Medications and Other Mental Health Services for Foster Children
NIH SPENT AN ESTIMATED $1.2 BILLION ON CHILDREN’S MENTAL HEALTH RESEARCH DURING FISCAL YEARS 2008 THROUGH 2011
Most NIH Funding for Children’s Mental Health Research Was Spent by NIMH
Other HHS Agencies Spent an Estimated $16 Million
on Children’s Mental Health Research Projects
APPENDIX I. METHODOLOGY USED TO ANALYZE
THE MEDICAL EXPENDITURE PANEL SURVEY
APPENDIX II. FOOD AND DRUG ADMINISTRATION REVIEWS OF PSYCHOTROPIC DRUG LABEL CHANGES
FOR CHILDREN
APPENDIX III. RESULTS OF THE MEDICAL EXPENDITURE PANEL SURVEY ANALYSIS
Chapter 2:
PSYCHOTROPIC MEDICATION USE
BY CHILDREN IN CHILD WELFARE
Characteristics of Children in the Sample
Measures of Psychotropic Medication Use, Emotional or Behavioral Health Problems, and Behavioral Health Service Use
USE OF PSYCHOTROPIC MEDICATIONS
USE OF ANTIPSYCHOTIC MEDICATIONS
BEHAVIORAL HEALTH SERVICE CONTEXT
Chapter 3:
PROMOTING THE SAFE, APPROPRIATE,
AND EFFECTIVE USE OF PSYCHOTROPIC MEDICATION FOR CHILDREN
IN FOSTER CARE
Prevalence of Psychotropic Medication Use Among Children
in Foster Care
Social-Emotional, Behavioral, and Mental Health Needs of Children with Child Welfare Involvement
Appropriateness of Psychotropic Medication Use Among Children
in Foster Care
Practice Guidelines Related to the Development of Protocolsfor the Appropriate Use and Monitoring of Psychotropic Medication
Federal Initiatives to Encourage the Appropriate Use
of Psychotropic Medication
ATTACHMENT A: CB REGIONAL OFFICE
PROGRAM MANAGERS